ABAlexander A. Buelow

Alexander A. Buelow

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexander A. Buelow has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Training status augments mechanisms of rapid‑onset vasodilation in healthy young adults

    by Matthew D. Stanford, Amir Akbari Fakhrabadi, Alexander A. Buelow, Jacob E Matney, Chris Mixon, Arinze J. Akubude, Ifechukwu Nwafor, Andriy Yabluchanskiy, Rebecca D. Larson, Daniel J. Larson, et al.

    Rapid onset vasodilation (ROV) is the immediate, transient increase in muscle blood flow following contraction and is mediated by chemical, mechanical, and, potentially, neural mechanisms. Although exercise training has been shown to preserve ROV in older adults, it remains unclear whether training promotes adaptation in specific contributing mechanisms. This study tested the hypothesis that a history of forearm training increases ROV. Sixteen healthy young males (8 trained, 8 sedentary) completed two trials of 1s voluntary forearm contractions (5, 10, 15kg; 20% and 100% of maximal voluntary contraction), electrically-stimulated involuntary contractions (5 and 10mA), and mechanical forearm compression (50, 200, 300mmHg) (randomly ordered). Forearm blood flow (ultrasound) and mean arterial pressure (finger photoplethysmography) were measured beat-to-beat and used to calculate Forearm vascular conductance (FVC). Data from the two trials of each contraction/compression were averaged together to form a singular response. Forearm and hand lean mass, as measured via dual-energy X-ray absorptiometry (DXA), did not differ between groups. Trained participants displayed greater absolute ROV responses to voluntary and involuntary contractions (p ≤ 0.05 for all), as well as to higher-intensity mechanical compressions (p ≤ 0.05 for 300mmHg ΔFVC total , 200mmHg and 300mmHg ΔFVC peak ). Additionally, ROV responses increased disproportionately with absolute voluntary contraction intensity in trained participants (Training Status x Intensity interaction ΔFVC total : p = 0.02, η p 2 = 0.29). These findings extend upon previous research which has demonstrated training-related preservation of ROV and indicate that exercise training enhances rapid vascular responsiveness across multiple stimulus modalities, providing new insight into training-induced adaptations in vascular regulation.

  • Open Access

    The effects of CYP450 inhibition on cerebrovascular control during rest and mild hypovolemia: An exploratory study in young, healthy adults

    by Jacob E. Matney, Alexander A. Buelow, Chris Mixon, Sarah M. Skillett, John D. Ashley, Jiwon Song, Amir Akbari Fakhrabadi, Paige Pointer, Justin D. Sprick, Christopher D. Black, et al.

    Cerebrovascular CYP450 is underexplored in humans. Twenty‐three participants (12 females) completed familiarization and two experimental visits utilizing double‐blind, randomized, crossover design. Participants ingested fluconazole (150 mg; FLZ, CYP450 inhibitor) or placebo (PLC, microcrystalline cellulose) followed by 120 min of supine rest. Five minutes of middle cerebral artery velocity (MCAv) and mean arterial pressure (MAP) were collected during rest (PLC/FLZ BASE ) and lower body negative pressure (LBNP; −20 mmHg; PLC/FLZ LBNP ). There was no interaction for MCAv, cerebrovascular conductance index (CVCi), resistance area product (RAP), critical closing pressure (CrCP), or transfer function variables. Bonferroni tests revealed only FLZ attenuated MCAv (FLZ BASE 75.2 ± 11.3 cm•s −1 vs. FLZ LBNP 70.6 ± 11.2 cm•s −1 , p = 0.015, d = 0.713) and CVCi (FLZ BASE 0.76 ± 0.12 cm•s −1 •mmHg −1 vs. FLZ LBNP 0.71 ± 0.11 cm•s −1 •mmHg −1 , p = 0.003, d = 0.865) during LBNP. LBNP lowered CrCP (PLC BASE 29.7 ± 9.3 mmHg vs. PLC LBNP 25.1 ± 11.3 mmHg, p = 0.002, d = 0.940) within PLC. RAP increased during LBNP (PLC BASE 0.96 ± 0.29 vs. PLC LBNP 1.08 ± 0.32, p = < 0.001, d = 1.28; FLZ BASE 0.98 ± 0.24 vs. FLZ LBNP 1.07 ± 0.23, p = < 0.001, d = 1.10). These data suggest a participatory, nonobligatory role of CYP450 in human cerebrovascular control.

  • Inhibition of cytochrome P-450 2C9 pathways attenuated flow-mediated dilation in males but not females

    by Amir Akbari Fakhrabadi, Alexander A. Buelow, Jacob E. Matney, Sarah M. Skillett, Jiwon Song, Christopher Mixon, Matthew D. Stanford, John D. Ashley, J. Mikhail Kellawan

    This study demonstrates that inhibiting CYP2C9 significantly reduces brachial artery flow-mediated dilation (FMD) in young, healthy adults, implicating CYP2C9-derived metabolites as a mediator of endothelium-dependent vasodilation. Notably, CYP2C9 inhibition attenuated FMD in males, whereas females maintained their vasodilatory response, suggesting sex-specific reliance on CYP2C9 signaling. These findings enhance our understanding of sex differences in vascular regulation and may inform future strategies for preserving endothelial health.


  • Inhibition of CYP450 pathways reduces functional sympatholysis in healthy young adults

    by Alexander A. Buelow, Jacob E. Matney, Sarah M. Skillett, John D. Ashley, Jiwon Song, Chris Mixon, Amir Akbari Fakhrabadi, Matthew Stanford, Debra A. Bemben, Daniel J. Larson, et al.

    Evidence suggests that functional sympatholysis is an endothelial-dependent, nitric oxide and prostaglandin-independent process. We found that cytochrome P450-2C9 (CYP450-2C9) inhibition attenuated sympatholytic responses during dynamic handgrip exercise with superimposed lower body negative pressure. These data indicate that CYP450 pathways contribute to functional sympatholysis in young healthy humans.